Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 339 of 5804
-
New drug duo targets hard-to-treat leukemias in early trial
Disease control Recruiting nowThe purpose of this study is to find out whether the combination of mezigdomide and revumenib is a safe treatment for people with relapsed or refractory KMT2A-r, NUP98-r, and NPM1-m acute leukemias.
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New stent could spare tiny hearts from early surgery
Disease control Recruiting nowStarlight Cardiovascular, Inc. is sponsoring a prospective, multi-center, study to evaluate safety and effectiveness of the Lifeline Ductus Arteriosus Stent System. The study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blo…
Phase: NA • Sponsor: Starlight Cardiovascular Inc • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for ulcerative colitis: Long-Term remission trial begins
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 286 …
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Triple-Drug attack on Hard-to-Treat stomach cancer shows promise in early trial
Disease control Recruiting nowThe ZANGEA trial is a open-label, single arm, multicenter phase II trial assessing the efficacy of zanidatamab in combination with pembrolizumab and chemotherapy in patients with metastatic gastroesophageal adenocarcinoma (GEA). The patients need to be previously untreated in the…
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New shot may stop hives from cold and scratching
Disease control Recruiting nowThe purpose of this Phase 3, randomized, double-blind, placebo-controlled study is to assess the activity and safety of barzolvolimab compared to placebo in participants with cold induced urticaria or symptomatic dermographism who remain symptomatic despite the use of H1-antihist…
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New heart tool aims to stop AFib Flare-Ups
Disease control Recruiting nowThe study is a prospective, single-arm, pre-market clinical study and will enroll up to 300 subjects at up to 26 sites in the United States (US) for analysis of primary objectives. No single site may contribute more than 15% of the enrollments.
Phase: NA • Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for recurrent brain cancer? drug combo trial launches
Disease control Recruiting nowThis multi-site Phase II study will enroll adults with histologically confirmed diagnosis of World Health Organization (WHO) Grade IV glioblastoma (GBM), isocitrate dehydrogenase (IDH)-wildtype consistent with WHO central nervous system (CNS) 2021 criteria who have received prior…
Phase: PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Promising drug duo targets Hard-to-Treat HER2 cancers
Disease control Not yet recruitingThis study is a prospective, multi-cohort clinical trial designed to evaluate the preliminary efficacy and safety of zanidatamab in combination with tislelizumab and chemotherapy/radiotherapy for patients with HER2-positive locally advanced or metastatic gastrointestinal tumors.
Phase: PHASE2 • Sponsor: Tao Zhang • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Smart scans aim to spare healthy lung during cancer radiation
Symptom relief Not yet recruitingStereotactic body radiotherapy (SBRT) has an increasing role in the treatment of both primary and secondary lung tumors. However, lung SBRT remains associated with significant radiation induced lung injury (RILI). Indeed, the reported incidence of symptomatic radiation induced lu…
Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Heart drug shows promise in prostate cancer fight
Disease control Not yet recruitingPropranolol, a non-selective adrenergic beta-receptor blocker, is conventionally used to treat arrhythmias. However, recent studies have demonstrated its therapeutic efficacy in breast cancer, prostate cancer, neonatal hemangioma, and neonatal facial rhabdomyoma. Given the signif…
Phase: NA • Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for rare anemias: drug may cut transfusions
Disease control Not yet recruitingThis is a prospective multicenter phase II basket trial evaluating Luspatercept in patients affected with rare inherited anemias
Phase: PHASE2 • Sponsor: EuroBloodNet Association • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
One-Dose immunotherapy before surgery shows promise for advanced melanoma
Disease control Recruiting nowA phase II double-blind placebo-controlled randomized trial. Patients with a clinical suspicion of a thick primary melanoma without clinical suspicion or evidence of lymph-node engagement will undergo a 3 mm punch biopsy to verify the diagnosis and ascertain eligibility. Patients…
Phase: PHASE2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New device aims to clear Stroke-Causing clots fast
Disease control Recruiting nowThe purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vess…
Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could steroids save lives in severe parrot fever pneumonia?
Disease control Not yet recruitingSevere community-acquired pneumonia caused by psittacosis is a form of atypical-pathogen community-acquired pneumonia that often requires critical care management. It can occur in immunocompetent adults, has an abrupt onset and rapid progression, and may quickly deteriorate to pr…
Phase: PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New lung cancer drug HB0025 faces off against standard therapy in major trial
Disease control Not yet recruitingThis study is a randomized, controlled, double-blind, multicenter Phase III registration clinical trial, aiming to evaluate the efficacy and safety of HB0025 combined with chemotherapy (pemetrexed plus carboplatin/cisplatin) versus tislelizumab combined with chemotherapy (pemetre…
Phase: PHASE3 • Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a 3-Week radiation course beat the standard 5-Week for cervical cancer?
Disease control Recruiting nowThe study is a prospective, randomized, non-inferiority clinical trial which will test whether a short course of radiation treatment (hypofractionation) for cervical cancer works as well as the standard longer course. Cervical cancer is one of the most common cancers in women in …
Phase: NA • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Spinal stimulation may restore function after Conus-Region injury
Disease control CompletedSpinal cord injury involving the conus region often results in severe impairments in mobility, self-care, and bladder and bowel function, substantially reducing independence and quality of life. Epidural electrical stimulation (EES), combined with structured rehabilitation, has e…
Sponsor: Istanbul Gelisim University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Heart drug repurposed to fight rare brain cancer in kids
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy of digoxin in treating relapsed non-SHH, non-WNT medulloblastoma in pediatric and young adult patients.
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Leukemia drug given as a shot shows promise in early trial
Disease control Recruiting nowThis is a multicenter, non-randomized, open-label, phase II study evaluating blinatumomab administered subcutaneously in adult subjects with CD19+ MPAL. This trial consists of three cohorts of patients with CD19-positive MPAL, categorized as follows: 1. Cohort A: Newly diagnosed …
Phase: PHASE2 • Sponsor: West Virginia University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for kidney cancer: drug combo after radiation shows promise in early trial
Disease control Recruiting nowThe purpose of this research is to test the safety of PD-1 inhibitor cemiplimab with or without LAG-3 inhibitor fianlimab, and see what effects (good and bad) of cemiplimab either alone or combined with fianlimab has on patients with oligometastatic clear cell renal cell carcinom…
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC